|
(P1679) |
Impaired mitochondrial function and increased oxidative stress enhance cardiac fibrosis induced by pressure overload in mice lacking telomerase activity |
| |
|
C. Perez-Ternero, C. Werner, A. Nickel, A. Kasakov, S. Jakob, J. Haendeler, J. Altschmied, M. Böhm, C. Maack, U. Laufs (Homburg/Saar, Düsseldorf) |
|
(P1680) |
The transcription factors GATA4 and GATA6 in cardiac fibroblasts promote cardiac dysfunction during pressure overload |
| |
|
N. Froese, H. Wang, M. Szaroszyk, M. Korf-Klingebiel, C. Zwadlo, B. Kattih, M. Malek Mohammadi, K. C. Wollert, J. Bauersachs, J. Heineke (Hannover) |
|
(P1681) |
ED-A+ Fibronectin: A novel serum biomarker for cardiac tissue remodeling in ischemic cardiomyopathy? |
| |
|
B. Ziffels, J. Ospel, K. Grün, M. Fritzenwanger, H.-R. Figulla, C. Schulze, C. Jung, A. Berndt, M. Franz (Jena, Düsseldorf) |
|
(P1682) |
Inhibition of myofibroblast differentiation by functional blocking of the ED-A domain of fibronectin using a human antibody: A potential novel strategy to prevent adverse cardiac remodelling? |
| |
|
M. Franz, K. Grün, N. Köse, M. Fritzenwanger, H.-R. Figulla, C. Schulze, C. Jung, A. Berndt (Jena, Düsseldorf) |
|
(P1683) |
Inhibition of Myofibroblast Differentiation by FOXO3a - Implications for acute myocardial infarction and cardiac Remodeling |
| |
|
M. Aslam, G. Weber, A. Jenke, L. Holzhauser, R. Schur, U. Landmesser, C. Skurk (Berlin) |
|
(P1684) |
Fibrosis depends on myofibroblast activation in atrial fibrillation |
| |
|
P. Lugenbiel, F. Wenz, K. Govorov, P. Syren, P. Schweizer, H. A. Katus, D. Thomas (Heidelberg) |